Table 4.
Parameters | Disease-Free Survival | Overall Survival | ||
---|---|---|---|---|
95% CI | p-Value | 95% CI | p-Value | |
HSL | 0.286 | N/A | ||
Negative | 104 (104–104) | N/A | ||
Positive | 187 (167–201) | N/A | ||
FABP4 | 0.573 | 0.326 | ||
Negative | 177 (154–200) | 183 (165–200) | ||
Positive | 111 (104–118) | 110 (100–120) | ||
CPT-1 | 0.004 | N/A | ||
Negative | 186 (168–203) | N/A | ||
Positive | 98 (87–108) | N/A | ||
Acyl-CoA oxidase 1 | 0.032 | 0.759 | ||
Negative | 185 (165–204) | 181 (162–199) | ||
Positive | 103 (90–115) | 117 (104–130) | ||
FASN | 0.150 | 0.787 | ||
Negative | 184 (165–204) | 178 (158–197) | ||
Positive | 103 (96–110) | 122 (116–127) |
CI, confidence interval; HSL, hormone-sensitive lipase; N/A, not applicable; FABP4, fatty acid binding protein 4; CPT-1, carnitine palmitoyltransferase 1; FASN, fatty acid synthetase. Significant values in bold.